An evaluation of potentially suitable fixatives for immunoperoxidase staining of estrogen receptors in imprints and frozen sections of breast carcinoma.
The estrogen receptor (ER) content of breast carcinoma is generally accepted as valuable in predicting clinical outcome and tumour response to hormonal manipulation. We applied a new immunocytochemical assay for estrogen receptors (Abbott ERICA Monoclonal) to 20 breast tumours, and examined the efficacy of 16 fixation procedures before immunoperoxidase staining of frozen sections and imprint preparations. Our findings indicate that the fixatives of choice are periodatelysine-paraformaldehyde at 22 degrees C, or 10% formalin followed by acetone at -10 degrees C. These fixation procedures are simpler, less time-consuming, and provide superior staining, tumour cytomorphology and higher ER values than the 3-reagent sequence recommended by Abbott Laboratories. There was a significant correlation between the ER scores in the frozen sections and the imprints. Positive ER cytosol results correlated with the staining index in the frozen sections, and the ER scores in the imprints. We conclude that imprints are suitable preparations for ER analysis by the immunoperoxidase technique, particularly for small tumour specimens.
Raymond
W A
WA
Tissue Pathology, Institute of Medical and Veterinary Science, Adelaide, South Australia.
Leong
A S
AS
D001943:Breast Neoplasms / Q000032:analysis* / Q000175:diagnosis; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000032:analysis*; D003600:Cytosol / Q000032:analysis; D005069:Evaluation Studies as Topic; D005260:Female; D005404:Fixatives; D005629:Frozen Sections; D006801:Humans; D007124:Immunoenzyme Techniques / Q000592:standards*; D008867:Microtomy; D011960:Receptors, Estrogen / Q000032:analysis*; D012016:Reference Values
D005404:Fixatives; D011960:Receptors, Estrogen